This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
EpiBone
Visit WebsiteEpiBone is a bone reconstruction company that advances skeletal reconstruction through 3D design and living cells.
EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
EpiBone’s technology works in a three-step process:
- Imaging and stem cell extraction
- Graft and bioreactor design
- Bone growth
Product:
EpiBone Bioreactor
This bioreactor is the product of 20 years’ research and experience with orthopaedic tissue engineering. Its function is to mimic the finely calibrated conditions of the human body that enable bone to grow. EpiBone’s technology uses a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a bone graft in the patented Bioreactor with the precise anatomical fit to the defect being treated. Bones that grow in the patented EpiBone bioreactor are ready in just three weeks, and continue to be remodelled and vascularized once they are transplanted into a patient.
Subsidiaries
Portfolio
- ProAxsis
- Glycotest
- Cetromed
- PDS Biotechnology
- Vortex Biosciences
- Wanda Health
- Q-Bot
- Sofant Technologies
- PointGrab
- SageTech Medical
- Dname-iT
- Oncocidia
- Ventive
- DeepTech Recycling
- G-Tech Medical
- FOx Biosystems
- EpiBone
- Cytovale
- Longevity Biotech
- QuantalX Neuroscience
- Insight Photonics
- Nanotech Industrial Solutions
- Martlet Capital